首页
400-620-6333
应用
选项
-
Recombinant Human IFN-alpha-1a Protein种属: 人(Human) Accession #: P01562表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to stimulate GBP2 expression in 293T human embryonic kidney cells. 0.1-1 ng/mL of Recombinant Human IFNA1 can effectively Stimulating GBP2 expression.
-
Recombinant Human EphB4 Protein种属: 人(Human) Accession #: P54760表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Testing in progress
-
Recombinant Human PD-1 Protein种属: 人(Human) Accession #: Q15116表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: 1. Immobilized Recombinant Human PD-1 Protein (rp176241) at 1.0 μg/mL can bind Toripalimab (anti-PD-1) (Ab182801) with the EC50 of 13.47 ng/mL. 2. Immobilized Recombinant Human PD-1 Protein (rp176241) at 1.0 μg/mL can bind Zimberelimab (anti-PD-1) (Ab175710) with the EC50 of 19.95 ng/mL. 3. Immobilized Recombinant Human PD-1 Protein (rp176241) at 1.0 μg/mL can bind Retifanlimab (anti-PD-1) (Ab175644) with the EC50 of 11.39 ng/mL. 4. Immobilized Recombinant Human PD-1 Protein (rp176241) at 1.0 μg/mL can bind Dostarlimab (anti-PD-1) (Ab175513) with the EC50 of 32.46 ng/mL. 5. Immobilized Recombinant Human PD-1 Protein (rp176241) at 1.0 μg/mL can bind Spartalizumab (anti-PD-1) (Ab169299) with the EC50 of 12.83 ng/mL. 6. Immobilized Recombinant Human PD-1 Protein (rp176241) at 1.0 μg/mL can bind Camrelizumab (anti-PD-1) (C412007) with the EC50 of 10.39 ng/mL. 7. Immobilized Recombinant Human PD-1 Protein (rp176241) at 1.0 μg/mL can bind Sintilimab (anti-PD-1) (Ab169307) with the EC50 of 15.02 ng/mL. 8. Immobilized Recombinant Human PD-1 Protein (rp176241) at 1.0 μg/mL can bind Cemiplimab (anti-PD-1) (C412010) with the EC50 of 12.82 ng/mL.
-
Recombinant Human DLL4 Protein种属: 人(Human) Accession #: Q9NR61表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: 1. Immobilized Recombinant Human DLL4 Protein (rp181238) at 5.0 μg/mL can bind Recombinant Human Notch-1 Protein (rp183726) with the EC50 of 26.54 ng/mL. 2. Immobilized Recombinant Human DLL4 Protein (rp181238) at 1.0 μg/mL can bind Navicixizumab (anti-DLL4) (Ab176598) with the EC50 of 69.79 ng/mL.
-
Recombinant Human TRAIL R2/TNFRSF10B Protein种属: 人(Human) Accession #: O14763表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Recombinant Human TRAIL R2/TNFRSF10B Protein (rp176693) inhibits Recombinant Human TRAIL mediated cytotoxicity using L-929 mouse fibroblast cells. The ED50 for this effect is 27.85 ng/mL. Immobilized Recombinant Human TRAIL R2/TNFRSF10B Protein (rp176693) at 5.0 μg/mL can bind Recombinant Human TRAIL Protein (rp169692) with the EC50 of 41.55 ng/mL.
-
Recombinant Human VCAM-1/CD106 Protein种属: 人(Human) Accession #: P19320表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Determined by its ability to support the adhesion of human U937 cells. The ED50 for this effect is 800.0-1000.0 ng/mL.
-
Recombinant Mouse HGF Protein种属: 小鼠(Mouse) Accession #: Q08048表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured in a cell proliferation assay using mIMCD‑3 mouse epithelial cells. The ED50 for this effect is 10-30 ng/mL. Measured by its ability to bind Recombinant Mouse HGF R/c-MET Fc Chimera in a functional ELISA with an estimated KD <0.2 nM.
-
Recombinant Human MMP-2 Protein种属: 人(Human) Accession #: P08253表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human MMP-2 Protein (rp181213) at 1.0 μg/mL can bind MMP2 Mouse mAb (Ab115657) with the EC50 of 23.04 ng/mL
-
Recombinant Human Siglec-3/CD33 Protein种属: 人(Human) Accession #: P20138表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: 1. Measured by the ability of the immobilized protein to support the adhesion of human red blood cells. The ED50 for this effect is < 6 µg/mL. 2. Immobilized Recombinant Human Siglec-3/CD33 Protein (rp169578) at 1.0 μg/mL can bind Vadastuximab (anti-CD33) (Ab182778) with the EC50 of 10.59 ng/mL. 3. Immobilized Recombinant Human Siglec-3/CD33 Protein (rp169578) at 1.0 μg/mL can bind Gemtuzumab (anti-CD33) (Ab175859) with the EC50 of 36.93 ng/mL.
-
Recombinant Human Siglec-2/CD22 Protein种属: 人(Human) Accession #: P20273表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human Siglec-2/CD22 Protein (rp169575) at 1.0 μg/mL can bind Inotuzumab (anti-CD22) (Ab176429) with the EC50 of 20.1 ng/mL. Immobilized Recombinant Human Siglec-2/CD22 Protein (rp169575) at 1.0 μg/mL can bind bind Epratuzumab (anti-CD22) (Ab175532) with the EC50 of 207.0 ng/mL.
-
Recombinant Human HE4/WFDC2 Protein种属: 人(Human) Accession #: Q14508表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Testing in progress
-
Recombinant Human TrkB Protein种属: 人(Human) Accession #: Q16620表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human TrkB Protein (rp181612) at 1.0 μg/mL can bind Rinat patent anti-TrkB (anti-TrkB) (Ab209857) with the EC50 of 34.2 ng/mL.
